Last reviewed · How we verify

NCT06594952

Evaluation of Maternal Mental Health Following Ultrasonography Detection of Fetal Congenital Anomalies

Not yet recruiting Last updated 19 September 2024
What this trial tests

trial testing Questionnaire and Physical Exam in Mental Disorder in 120 participants. Not yet recruiting.

Timeline
1 October 2024
Primary endpoint
1 August 2025
1 September 2025

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment120
Start date1 October 2024
Primary completion1 August 2025
Estimated completion1 September 2025

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

18 and older, female only, with Mental Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate maternal mental health during antenatal and postnatal periods after Ultrasonography diagnosis of fetal anomalies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire and Physical Exam

Trials testing the same drug.

Other recruiting trials for Mental Disorder

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing